ストックスクリーナーアプリを入手
6.65
0.00%
0.00
アフターアワーズ：
6.65
前日終値:
$6.65
開ける：
$6.54
24時間の取引高:
478.30K
Relative Volume:
0.90
時価総額：
$361.83M
収益：
$250.01M
当期純損益:
$132.33M
株価収益率:
2.9295
EPS:
2.27
ネットキャッシュフロー:
$74.66M
1週間 パフォーマンス:
-5.94%
1か月 パフォーマンス:
-5.54%
6か月 パフォーマンス:
-24.52%
1年 パフォーマンス:
-0.89%
1日の値動き範囲:
$6.4009
$6.69
1週間の範囲:
$6.4009
$7.23
52週間の値動き範囲:
$5.71
$11.72
Voyager Therapeutics Inc Stock (VYGR) Company Profile
名前
Voyager Therapeutics Inc
セクター
電話
857-259-5340
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-05-10 | 開始されました | Truist | Buy |
| 2023-03-10 | 開始されました | Oppenheimer | Outperform |
| 2021-10-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-02-03 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-12-24 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-11-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 開始されました | The Benchmark Company | Buy |
| 2020-02-06 | 開始されました | Oppenheimer | Outperform |
| 2018-11-15 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-09-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-02-02 | 開始されました | Morgan Stanley | Overweight |
| 2017-11-28 | 再開されました | Piper Jaffray | Overweight |
| 2017-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2017-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2017-10-23 | 繰り返されました | Stifel | Buy |
| 2017-10-12 | 開始されました | Raymond James | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-28 | 再開されました | Stifel | Buy |
すべてを表示
Voyager Therapeutics Inc (VYGR) 最新ニュース
VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - StockTitan
Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World
StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat
Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Upgraded at Leerink Partnrs - MarketBeat
Improved Revenues Required Before Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock's 27% Jump Looks Justified - Simply Wall St
Leerink Partners Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics - Benzinga
The Manufacturers Life Insurance Company Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Gene Therapy in CNS Disorder Market Rapid Growth at Deep Value Price :Voyager Therapeutics, Spark Therapeutics, Novartis – IndiaPolitics.com - IndiaPolitics.com
(VYGR) Technical Pivots with Risk Controls - Stock Traders Daily
Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance
Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Short Interest Update - MarketBeat
Voyager Therapeutics Inc (VYGR)’s Market Momentum: Closing Strong at 6.76, Down -4.52 - The Dwinnex
Monitoring Voyager Therapeutics Inc (VYGR) after recent insider movements - Knox Daily
Analyzing the Impact of Earnings Reports on Voyager Therapeutics Inc Inc. (VYGR) Price Performance - The InvestChronicle
Nothing is Better Than Voyager Therapeutics Inc (VYGR) stock at the moment - SETE News
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Holdings Lessened by Dimensional Fund Advisors LP - MarketBeat
Are Voyager Therapeutics Inc (VYGR) shares a good deal now? - US Post News
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - Yahoo Finance
Strong week for Voyager Therapeutics (NASDAQ:VYGR) shareholders doesn't alleviate pain of five-year loss - Simply Wall St
AQR Capital Management LLC Sells 291,259 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k By Investing.com - Investing.com Australia
Voyager Therapeutics Inc [VYGR] stock for 34,914 USD was sold by Fahey Sandell Jacquelyn - Knox Daily
Voyager Therapeutics Inc (VYGR) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
What is the investor’s view on Voyager Therapeutics Inc (VYGR)? - US Post News
(VYGR) Technical Data - Stock Traders Daily
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Insider Sells $34,914.18 in Stock - MarketBeat
Voyager Therapeutics executive sells shares worth over $34k - Investing.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M - MSN
Armistice Capital LLC Raises Stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics stock hits 52-week low at $5.95 By Investing.com - Investing.com Australia
Baird maintains Outperform rating on Voyager Therapeutics stock By Investing.com - Investing.com Canada
Closing Figures: Voyager Therapeutics Inc (VYGR)’s Negative Finish at 6.04, Down -0.98 - The Dwinnex
Voyager Therapeutics stock hits 52-week low at $5.95 - Investing.com
Great Point Partners LLC Invests $12.67 Million in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
What is Voyager Therapeutics Inc (VYGR) Stock Return on Shareholders’ Capital? - SETE News
(VYGR) Trading Report - Stock Traders Daily
Voyager Therapeutics Inc (VYGR) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):